AG真人官方

NVIDIA CEO & President Jen-Hsun Huang filed Form 4 disclosing the sale of 225,000 NVDA common shares on 29鈥�31 Jul 2025 under a pre-arranged Rule 10b5-1 trading plan adopted 20 Mar 2025. Sale prices ranged from $175.27-$183.20, implying gross proceeds of roughly $40 million.

After the transactions, direct ownership fell from 73.90 M to 73.67 M shares. Huang continues to control an additional ~783 M shares indirectly through family trusts, partnerships and LLCs, leaving total beneficial ownership near 857 M shares. Thus, the disposition equals <0.03 % of his total stake and does not materially alter insider alignment.

No derivative activity was reported. Because the trades were executed via a 10b5-1 plan and represent a de-minimis fraction of holdings, the filing is generally seen as routine liquidity rather than a signal of deteriorating insider confidence.

NVIDIA Corp. (NVDA) has filed a Form 144 indicating that President & CEO Jensen (Jen-Hsun) Huang intends to sell 75,000 common shares on 31 Jul 2025 through Charles Schwab. The shares, acquired via an option exercise on 15 Sep 2023, carry an estimated aggregate market value of $13.5 million (鈮�$180 per share).

The filing also details Huang鈥檚 recent activity: over the past three months he executed 28 separate sales totaling roughly 2.0 million shares for 鈮�$332 million in gross proceeds, with individual blocks of 50 k鈥�75 k shares sold between 20 Jun 2025 and 30 Jul 2025. The newly proposed sale would raise disclosed dispositions to about 2.1 million shares.

Form 144 serves only as advance notice; execution is not guaranteed and transactions may be made under a Rule 10b5-1 trading plan. The document contains no operational or earnings information.

Bank7 Corp. (BSVN) filed a Form 4 showing President & CEO Thomas L. Travis acquired 4,364 common shares on 29 Jul 2025. The transaction is coded 鈥淎,鈥� indicating an award/grant at $0 cost, effectively a new block of restricted-stock units (RSUs). Following the grant, Travis鈥� direct beneficial ownership increases to 299,377 shares. No sales or derivative security trades were reported.

The filing lists several outstanding RSU awards that vest in staged installments through 2028, totalling roughly 40 k units, underscoring long-term incentive alignment: 4,364 units vesting 2026-2028; 14,420 units vesting 2026-2028; 3,750 units completing in 2025; 10,991 units vesting 2025-2027; and 6,768 units vesting 2024-2026. No changes to derivative positions, option exercises, or insider sales were disclosed.

The grant marginally raises executive ownership but represents an immaterial percentage of Bank7鈥檚 overall float; therefore, the market impact is expected to be neutral while still signalling management鈥檚 ongoing commitment.

Atlas Venture funds have filed Amendment No. 1 to their Schedule 13D for ImageneBio, Inc. (formerly Ikena Oncology, Nasdaq: IKNA) to report dilution of their holdings after the 1-for-12 reverse stock split and completion of Ikena鈥檚 all-stock merger with Inmagene on 25 Jul 2025.

• Collectively, the reporting entities now own 418,179 post-split common shares, equal to 3.6 % of the 11.6 million shares outstanding.
• Breakdown: Fund X 241,800 shares (2.1 %), Fund XI 103,494 shares (0.9 %), Opportunity Fund I 72,885 shares (0.6 %).
• All voting and dispositive powers are shared among the respective limited partnerships and their general partners; no sole voting power is reported.
• The funds ceased to be 5 % beneficial owners on 25 Jul 2025; no purchases or sales occurred in the past 60 days.
• Purpose: administrative update reflecting dilution from the merger and reverse split; Atlas Venture continues to hold the same absolute number of economic shares pre-transaction but a lower percentage.

Atlas Venture disclaims group status among the reporting persons. A joint filing agreement is included as Exhibit 99.1.

Triumph Group, Inc. (TGI) 鈥� Form 4 discloses that director Courtney Mather disposed of her entire equity stake on 24 Jul 2025 as a direct result of the company鈥檚 merger with Titan BW Acquisition Holdco.

• 22,178 common shares (including 10,324 RSUs) were automatically cancelled and converted into the right to receive $26.00 in cash per share, the consideration specified in the February 2, 2025 Merger Agreement.
• No derivative securities were outstanding or exercised, and post-transaction beneficial ownership is 0 shares.

The Form 4 is a procedural notice confirming the cash-out of insider holdings and the legal completion of the merger, rather than a discretionary trade.

Brown & Brown, Inc. (NYSE: BRO) filed a Form 8-K on 28 Jul 2025. The sole purpose of the filing is to furnish鈥攗nder Item 2.02鈥攊ts press release announcing second-quarter results for the period ended 30 Jun 2025. The earnings release itself is provided as Exhibit 99.1 but is not included in the text of this submission, so no financial metrics are disclosed here.

The company clarifies that the information is furnished, not filed, thereby limiting liability under Exchange Act 搂18 and preventing automatic incorporation by reference into Securities Act filings unless expressly stated. No other material events, transactions, or changes in financial condition are reported. Exhibit 104 supplies the inline XBRL cover-page data.

Form 144 鈥� Insider share sale notice

NVIDIA CEO Jen-Hsun Huang has filed to sell an additional 75,000 common shares on 25 Jul 2025 through Charles Schwab, valued at $13.0 million (aggregate market value). The filing also shows Huang has already disposed of approximately 1.73 million shares between 20 Jun and 24 Jul 2025 in daily blocks of 50-75 k, generating about $280 million in gross proceeds. The planned transaction equals less than 0.01 % of the reported 24.4 billion shares outstanding, but extends a multi-week liquidation program by the company鈥檚 founder and chief executive.

While Form 144 is only a notice and execution is not guaranteed, continued insider selling can pressure sentiment鈥攅specially after NVDA鈥檚 sharp appreciation. Investors will watch for further filings, Rule 10b5-1 plan details, and the market鈥檚 ability to absorb additional supply.

Coca-Cola Consolidated (COKE) Q2-25 10-Q highlights

• Net sales rose 3.3% YoY to $1.86 bn; first-half sales up 1.4% to $3.44 bn.
• Gross profit +3.6% to $742 m; gross margin steady at 40.0%.
• Operating income +5.0% to $272 m; operating margin 14.7% (+30 bp).
• Net income increased 8.5% to $187 m; diluted EPS $2.15 (+16%). First-half EPS $3.34 (-8%).
• Interest expense swung to a $6 m cost from a $2 m benefit YoY, reflecting higher average debt after 2024 bond issuance.
• Mark-to-market expense on acquisition-related contingent consideration fell to $12 m vs $28 m, easing below-the-line pressure.
• 1H-25 operating cash flow slipped 7% to $406 m; capex $157 m kept free cash flow modest.
• Cash & equivalents climbed to $1.22 bn; total debt unchanged at $1.79 bn, leaving net debt of $0.57 bn.
• Equity strengthened to $1.63 bn as retained earnings rose and buybacks ($35 m) reduced share count under the $1 bn program.
• Dividend lifted to $0.25 per share post 10-for-1 split effective 27-May-25.

Takeaway: Stable volume-driven revenue growth and cost discipline are expanding margins, but higher financing costs and softer first-half earnings temper the story. Robust liquidity and active capital returns support shareholder value.

Yelp Inc. (YELP) 鈥� Form 4 Insider Transaction

Chief Product Officer Craig Saldanha disclosed a sale of 1,000 common shares on 07/23/2025. The transaction, coded 鈥淪,鈥� was executed at $35.23 per share under a Rule 10b5-1 trading plan adopted 08/30/2024, generating proceeds of roughly $35k. After the sale, Saldanha still directly owns 212,720 shares, meaning he reduced his holding by less than 0.5 %. No derivative securities were involved, and no other insiders are listed on the filing.